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ABSTRACT
Objective: We hypothesised that frailty assessment is
of additional value to predict delirium and mortality
after transcatheter aortic valve implantation (TAVI).
Methods: Observational study in 89 consecutive
patients who underwent TAVI. Inclusion from
November 2012 to February 2014, follow-up until April
2014. Measurement of the association of variables
from frailty assessment and cardiological assessment
with delirium and mortality after TAVI, respectively.
Results: Incidence of delirium after TAVI: 25/89
(28%). Variables from frailty assessment protectively
associated with delirium were: Mini Mental State
Examination, (OR 0.79; 95% CI 0.65 to 0.96; p=0.02),
Instrumental Activities of Daily Living (OR 0.79; 95%
CI 0.63 to 0.99; p=0.04) and gait speed (OR 0.05;
95% CI 0.01 to 0.50; p=0.01). Timed Up and Go was
predictively associated with delirium (OR 1.14; 95% CI
1.03 to 1.26; p=0.01). From cardiological assessment,
pulmonary hypertension was protectively associated
with delirium (OR 0.34; 95% CI 0.12 to 0.98; p=0.05).
Multivariate logistic analysis: Nagelkerke R2=0.359,
Mini Mental State Examination was independently
associated with delirium. Incidence of mortality: 11/89
(12%). Variables predictively associated with mortality
were: the summary score Frailty Index (HR 1.66, 95%
CI 1.06 to 2.60; p=0.03), European System for Cardiac
Operative Risk Evaluation (EuroSCORE) II (HR 1.14,
95% CI 1.06 to 1.22; p<0.001) and complications (HR
4.81, 95% CI 1.03 to 22.38; p=0.05). Multivariate Cox
proportional hazards analysis: Nagelkerke R2=0.271,
Frailty Index and EuroSCORE II were independently
associated with mortality.
Conclusions: Delirium frequently occurs after TAVI.
Variables from frailty assessment are associated with
delirium and mortality, independent of cardiological
assessment. Thus, frailty assessment may have
additional value in the prediction of delirium and
mortality after TAVI.
INTRODUCTION
Severe symptomatic aortic stenosis occurs in
3.4% of patients aged >75 years,1 for which
the standard treatment is surgical aortic valve
replacement. However, in patients with older
age and left ventricular dysfunction surgery
is often denied.2
Transcatheter aortic valve implantation
(TAVI) has been developed as an alternative
to surgical aortic valve replacement in high-
risk patients with symptomatic aortic valve
stenosis. TAVI has been shown to be superior
KEY QUESTIONS
What is already known about this subject?
▸ Severe aortic stenosis occurs in 3.4% of
patients aged >75. Transcatheter aortic valve
implantation (TAVI) is less invasive compared
with the standard surgical procedure and may
therefore be performed in elderly patients at
high risk.
▸ Guidelines advocate to include frailty into the
risk models for TAVI.
▸ Delirium frequently occurs after TAVI (12–53%),
is associated with mortality, morbidity and
increased costs, whereas it is often unrecog-
nised and may be preventable in 30–40% of
cases.
▸ Previous studies showed no relation between
frailty and delirium after TAVI.
What does this study add?
▸ To our best knowledge, this study is the first to
investigate the association of objective frailty
assessment with delirium in a specific group of
patients after TAVI. This study reveals that from
frailty assessment the separate variables: Mini
Mental State Examination, Instrumental Activities
of Daily Living, gait speed and Timed Up and
Go are associated with delirium after TAVI. The
summary score Frailty Index is associated with
mortality, independent of cardiological
assessment.
How might this impact on clinical practice?
▸ In elderly patients with symptomatic aortic sten-
osis, frailty assessment may improve identifica-
tion of patients at high risk for delirium and
mortality, and thus improve treatment stratifica-
tion with proactive implementation of preventive
strategies.
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to medical treatment,3 4 while survival rates are similar or
even higher compared with surgical aortic valve replace-
ment.5 6 Nevertheless, in these high-risk elderly patients,
morbidity and mortality after TAVI is substantial; 1-year
mortality was 14.2–19% and 2-year mortality was 33.9–
43.3%.3–6 Although reduction of mortality is noted,7
adequate risk assessment in this population is mandatory.
The European System for Cardiac Operative Risk
Evaluation (EuroSCORE) is widely used to predict
operative mortality in cardiac surgery. However, this
model was developed and validated in a standard surgi-
cal risk population. Frailty, deﬁned as a syndrome of
impaired physiological reserve and decreased resistance
to stressors, has been shown useful to identify patients at
increased risk of mortality after TAVI.8–10 Therefore, a
risk model for elderly and high-risk patients undergoing
TAVI should comprise frailty.11–13
Delirium frequently occurs after TAVI; incidence
12–53%.14–16 In-hospital delirium is associated with mor-
tality, morbidity and increased costs, whereas it is often
unrecognised and may be preventable in 30–40% of
cases.17 18 As a potent indicator of patients’ safety, delirium
provides a target for system-wide process improvements.17
Frailty has been shown to be associated with postoperative
delirium.19 20 In patients referred for TAVI, predictive
models for delirium may be useful to identify high-risk
patients, to allow treatment stratiﬁcation and proactive
implementation of preventive strategies.17 21 Investigations
were performed to identify risk factors associated with
delirium after cardiac surgery, including TAVI.14–16 20
Previous investigators found no relation between frailty
and delirium after TAVI, however, in these studies variables
of frailty were not objectively assessed.15 16
The aim of this study is to reveal the value of objective
frailty assessment, in addition to cardiological assess-
ment, to identify variables associated with delirium and
mortality in patients undergoing TAVI.
METHODS
Study setting, participants and treatment assignment
The study was conducted in a single tertiary referral
centre. Between November 2012 and February 2014 data
from 305 patients with severe symptomatic aortic valve
stenosis referred for aortic valve replacement were
reviewed by a heart team consisting of a cardiothoracic
surgeon, an interventional cardiologist and a general or
imaging cardiologist. Based on the available cardio-
logical data, 177 patients were primarily considered can-
didates for surgical aortic valve replacement and
underwent routine preoperative screening. The remain-
ing 128 patients were considered as high-risk or poten-
tially frail. These patients were referred to a specialised
pre-TAVI outpatient clinic, where patients were assessed
by a multidisciplinary team consisting of a cardiac anaes-
thesiologist, a cardiac surgeon, a cardiologist and a
geriatrician. Based on consensus from this team and the
patient, 91 patients were assigned to TAVI, 18 to surgical
aortic valve replacement and 19 to medical treatment,
ﬁgure 1. Two patients assigned to TAVI died before the
procedure was performed.
Baseline measures
Cardiological assessment
In the heart team patients were discussed based on
reported patient history and routine cardiological exam-
ination including echocardiography, coronary angiog-
raphy and additional imaging with respect to access site
and suitability for TAVI, when appropriate. In addition,
EuroSCORE I and EuroSCORE II variables were
obtained (age, gender, renal impairment, extracardiac
arteriopathy, subjective poor mobility, previous cardiac
surgery, chronic lung disease, diabetes on insulin,
New York Heart Association (NYHA) classiﬁcation, left
ventricular function, pulmonary hypertension).
At the pre-TAVI outpatient clinic, cardiological assess-
ment consisted of patient history, physical examination
and ECG.
Frailty assessment
Geriatric assessment consisted of patient history,
(hetero)anamnesis, medication review and the following
speciﬁc instruments for frailty assessment: Mini Mental
State Examination (range 0–30, with higher scores indi-
cating better cognitive status),22 Basic Activities of Daily
Living (range 0–20, with higher scores indicating better
functional performance) and Instrumental Activities of
Daily Living (range 0–8, with higher scores indicating
better functional performance), mobility: gait speed
(m/s, velocity measured over a distance of 4 m, with
higher scores indicating better mobility) and/or Timed
Up and Go (TUG) test (seconds, with lower scores indi-
cating better mobility), Mini Nutritional Assessment
(range 0–14, with scores below 12 indicating risk of mal-
nutrition). Frailty Index (range 0–5, with higher scores
indicating frailer status) was calculated as a summary
score from these baseline components: 1 point was
assigned for Mini Mental State Examination ≤27; Basic
Activities of Daily Living ≥1 limited activity; Instrumental
Activities of Daily Living ≥1 limited activity; Mini
Nutritional Assessment <12; impaired mobility: when
neither gait speed over 4 m ≥0.75 m/s nor TUG<12.5 s,
respectively. Clinical judgement from the geriatrician
about frailty and risk for delirium were noted as vari-
ables, in addition to the objective frailty assessment, as
obtained by this geriatrician.
TAVI procedure
All procedures were performed under general anaesthe-
sia; oxazepam and paracetamol were given as premedica-
tion 1 hour prior to transfer to the catheterisation
laboratory. General anaesthesia was induced using sufen-
tanil and midazolam. The Medtronic CoreValve
(Medtronic, Minneapolis, Minnesota, USA) was used,
with surgical vascular access through the left subclavian
artery, which is the access site of choice in our centre.
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After TAVI, patients were admitted to the intensive care
unit for the ﬁrst day, weaning from ventilation within
2–4 hours after admission, with subsequent transfer to
the coronary care unit the following day.
Outcomes
Incidence of delirium
The hospital has a multidisciplinary guideline for pre-
vention, diagnosis and treatment of delirium, including
postprocedural Delirium Observation Scales and obser-
vations from attending physicians and nurses. Delirium
was deﬁned according to the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV)
comprising the following features: (1) disturbance in
consciousness with reduced ability to focus, sustain, or
shift attention; (2) change in cognition or the develop-
ment of a perceptual disturbance; (3) acute onset and
ﬂuctuating course and (4) evidence of an organic aetio-
logical factor. A geriatric consultation team assessed the
diagnosis delirium on a daily basis during hospital stay.
Incidence of mortality
All-cause mortality was assessed, based on registration of
in-hospital mortality, supplemented with data from
follow-up, the hospital electronic patient ﬁle, and by
calling the general practitioner to check for patients lost
to follow-up. Mortality data were obtained until 1 April
2014.
Data analysis
Univariate logistic regression analysis was performed
to identify a relation of variables with the incidence of
delirium. Univariate Cox proportional hazards regres-
sion analysis was performed to identify a relation
between the variables and all-cause mortality, mea-
sured from the date of TAVI until mortality or end of
follow-up (days). Multivariate logistic regression ana-
lysis was performed by using age and the variables
related with incidence of delirium and mortality, as
measured with univariate logistic regression analysis
and univariate Cox proportional hazards regression
analysis, respectively, with a signiﬁcance level p<0.05.
When variables were mutually strongly related, as
expected from the nature of the variables and con-
ﬁrmed by Pearson’s correlation for interval/ratio vari-
ables or Spearman’s correlation for ordinal variables,
a variable was selected for exclusion from the multi-
variate logistic regression analysis. The quality of the
multivariate regression and Cox proportional hazards
models is provided with Nagelkerke R2. For variables
signiﬁcantly related with delirium or mortality, by uni-
variate analysis, the independent samples Student’s
t-test was used for interval variables and the χ2 test for
categorical variables, to assess differences in mean
score or proportion in patients with or without delir-
ium and mortality, respectively. All statistical analyses
were performed using SPSS 22.0 (IBM Corp., Armonk,
New York, USA).
Figure 1 Flow chart of procedure for treatment assignment. MT, medical therapy; SAVR, surgical aortic valve replacement;
TAVI, transcatheter aortic valve implantation.
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RESULTS
Incidence and severity of delirium
Baseline characteristics and clinical outcome during
follow-up are shown in table 1.
The incidence of postprocedural delirium was in 25/
89 (28%) patients, table 1. The median onset of delir-
ium was on day 2 (IQR 1.5–2.5 days), with a median dur-
ation of 2 days (IQR 0.5–3.5 days). Haloperidol was
given to 29/89 (33%) patients; it was prescribed for
treatment of delirium in 24 patients and for prevention
of delirium in 5 patients with a history of delirium, of
whom 1 patient developed a postprocedural delirium.
The median total amount of haloperidol given for treat-
ment of delirium was 3.5 mg (IQR 2.5–4.5 mg) over a
median period of 2.5 days (IQR 1.0–4.0 days).
Variables associated with delirium after TAVI—univariate
analysis
Variables signiﬁcantly associated with delirium were: pul-
monary hypertension (OR per unit change 0.43; 0.19 to
0.96; p=0.04), Mini Mental State Examination (OR 0.79;
95% CI 0.65 to 0.96; p=0.02), impaired Instrumental
Activities of Daily Living (OR 0.79; 95% CI 0.63 to 0.99;
p=0.04), gait speed (OR 0.05; 95% CI 0.01 to 0.50;
p=0.01), TUG (OR 1.14; 95%; CI 1.03 to 1.26; p=0.01)
and clinical judgement of frailty (OR 3.10; 95% CI 1.14
to 8.46; p=0.03), table 2. Thus, patients with lower sys-
tolic pulmonary artery pressure, lower Mini Mental State
Examination score, lower Instrumental Activities of Daily
Living performance, lower gait speed, higher TUG score
or with a clinical judgement of frailty were at higher risk
to develop postprocedural delirium.
Variables associated with mortality after TAVI—univariate
Cox proportional hazards regression analysis
Within the ﬁrst 30 days after TAVI 5/89 patients died
(5.6%). After a median follow-up of 195 days (IQR 69–
321 days) mortality was 11/89 (12.4%), table 1.
Variables signiﬁcantly associated with mortality, measured
by univariate regression analysis were: EuroSCORE I (HR
Table 1 Baseline characteristics and clinical outcome during follow-up
Transcatheter aortic valve implantation n=89
Baseline—cardiological assessment
Age, mean (SD), year 80.4 (6.3)
Weight, mean (SD), kg 73.6 (15.0)
Body mass index, mean (SD), kg/m2 26.9 (4.9)
Gender, male, n (%) 38 (43)
Renal impairment <50 mL/min/1.73 m2, n (%) 47 (53)
Extracardiac arteriopathy, n (%) 24 (27)
Subjective poor mobility, n (%) 8 (9)
Previous cardiac surgery, n (%) 1 (1)
Chronic lung disease, n (%) 20 (22)
Diabetes on insulin, n (%) 24 (27)
New York Heart Association (classification) III or IV, n (%) 77 (87)
Ejection fraction ≤30%, n (%) 5 (6) n=78
Pulmonary hypertension >30 mm Hg, n (%) 55 (72) n=76
EuroSCORE I, mean (SD) 15.9 (9.8)
EuroSCORE II, mean (SD) 5.4 (5.0)
Aortic valve area, mean (SD), cm2 0.72 (0.25)
Aortic valve peak gradient, mean (SD), mm Hg 75.7 (22.6)
Baseline—frailty assessment
Mini Mental State Examination (range 0–30), mean (SD) 27.0 (2.5)
Basic Activities of Daily Living (range 0–20), mean (SD) 18.5 (1.8)
Instrumental Activities of Daily Living (range 0–8), mean (SD) 6.4 (2.0)
Gait speed, mean (SD), m/s 0.84 (0.3)
Timed Up and Go, mean (SD), seconds 12.8 (6.2)
Mini Nutritional Assessment (range 0–14), mean (SD) 11.7 (2.5)
Frailty Index (range 0–5), mean (SD) 2.38 (1.47)
Clinical judgement frail, n (%) 47 (53)
Clinical judgement high risk for delirium, n (%) 65 (73)
Clinical outcome
TIA/CVA, n (%) 1 (1)
Renal failure, n (%) 0 (0)
Gastric bleeding, n (%) 1 (1)
Vascular complications, n (%) 3 (3)
Postprocedural incidence of delirium, in-hospital, n (%) 25 (28)
Mortality (all-cause), median follow-up 195 days (IQR 69–321 days), n (%) 11 (12)
CVA, Cerebrovascular Accident; EuroSCORE, European System for Cardiac Operative Risk Evaluation; TIA, Transient Ischemic Attack.
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1.08; 95% CI 1.03 to 1.13; p=.002), EuroSCORE II (HR
1.14; 95% CI 1.06 to 1.22; p<0.001), Frailty Index (HR
1.66; 95% CI 1.06 to 2.60; p=.03) and postoperative compli-
cations (HR 4.81; 95% CI 1.03 to 22.38; p=.05), table 2.
Variables associated with delirium after TAVI—
multivariate logistic regression analysis
Clinical judgement of frailty is a subjective interpretation
of frailty, obtained by a geriatrician with access to the
results of frailty assessment and thus correlated with the
separate variables (Instrumental Activities of Daily
Living, r=0.44; gait speed, r=0.53; TUG, r=0.49) and with
the objective summary score Frailty Index (r=0.59).
Furthermore, gait speed and TUG are strongly corre-
lated (r=0.73), whereas gait speed was signiﬁcantly
related to Mini Mental State Examination (r=0.31).
Therefore, we performed multivariate regression analysis
after exclusion of clinical judgement of frailty and gait
speed, table 3. Quality of the model, Nagelkerke
R2=0.359, Mini Mental State Examination was independ-
ently associated with delirium, table 3.
Variables associated with mortality after TAVI—
multivariate Cox proportional hazards regression analysis
EuroSCORE II is the renewed version of EuroSCORE I,
partly consisting of the same variables. EuroSCORE I
and EuroSCORE II are strongly correlated (r=0.86).
Therefore, multivariate Cox proportional hazard regres-
sion analysis was performed after exclusion of
EuroSCORE I, Quality of the model, Nagelkerke
R2=0.271, revealing Frailty Index and EuroSCORE II as
independently associated with mortality table 3.
Mean values variables associated with delirium and
mortality
Mean values for those variables signiﬁcantly associated
with delirium and mortality are presented for the
groups with or without the occurrence of delirium and
mortality, respectively, in table 4.
Three of the 25 patients with delirium died (12%)
versus 8 of the 64 patients without delirium (12.5%,
p=ns). We found no relation between delirium and
mortality.
Table 2 Variables associated with delirium and mortality after transcatheter aortic valve implantation (TAVI)
Variables associated with
delirium
Variables associated with
mortality
Univariate regression analysis OR 95% CI p Value HR 95% CI p Value
Baseline cardiological assessment
Age, year 1.05 0.97 to 1.14 0.22 0.98 0.89 to 1.07 0.62
Weight, kg 0.99 0.96 to 1.02 0.58 0.98 0.94 to 1.03 0.39
Body mass index, kg/m2 1.02 0.93 to 1.12 0.65 0.95 0.83 to 1.09 0.46
Gender, male 0.68 0.26 to 1.76 0.43 0.47 0.12 to 1.76 0.26
Renal impairment <50 mL/min/1.73 m2 0.61 0.24 to 1.55 0.30 2.21 0.59 to 8.34 0.24
Extracardiac arteriopathy 0.59 0.19- 1.81 0.36 1.51 0.44 to 5.16 0.51
Chronic lung disease 1.75 0.52 to 5.87 0.37 1.99 0.58 to 6.79 0.27
Diabetes on insulin 1.24 0.43 to 3.60 0.69 1.58 0.46 to 5.40 0.47
New York Heart Association (classification) III or IV 0.80 0.21 to 3.37 0.36 0.77 0.17 to 3.56 0.73
Subjective poor mobility 1.61 0.35 to 7.30 0.54 0.04 0.00 to 439.11 0.50
Ejection fraction ≤30% 1.65 0.26 to 10.60 0.60 1.23 0.16 to 9.67 0.84
Pulmonary hypertension (0–30/31–55/>55 mm Hg) 0.43 0.19 to 0.96 0.04* 1.30 0.49 to 3.49 0.60
EuroSCORE I 1.00 0.95 to 1.05 0.97 1.08 1.03 to 1.13 0.002*
EuroSCORE II 1.00 0.91 to 1.10 0.95 1.14 1.06 to 1.22 <0.001*
Aortic valve area, cm2 1.58 0.19 to 12.90 0.67 0.11 0.01 to 1.95 0.13
Aortic valve peak gradient, mm Hg 1.00 0.97 to 1.02 0.79 0.98 0.95 to 1.02 0.31
Baseline frailty assessment
Mini Mental State Examination, range 0–30 0.79 0.65 to 0.96 0.02* 0.98 0.77 to 1.25 0.89
Basic Activities of Daily Living, range 0–20 1.00 0.78 to 1.30 0.98 0.86 0.66 to 1.12 0.26
Instrumental Activities of Daily Living, range 0–8 0.79 0.63 to 0.99 0.04* 0.92 0.71 to 1.20 0.53
Gait speed, m/s 0.05 0.01 to 0.50 0.01* 0.11 0.01 to 1.43 0.09
Timed Up and Go, seconds 1.14 1.03 to 1.26 0.01* 1.04 0.94 to 1.16 0.46
Mini Nutritional Assessment, range 0–14 0.99 0.82 to 1.20 0.91 0.92 0.74 to 1.14 0.44
Frailty Index, range 0–5 1.25 0.90 to 1.73 0.18 1.66 1.06 to 2.60 0.03*
Clinical judgement frailty, 0–1 3.10 1.14 to 8.46 0.03* 3.92 0.85 to 18.16 0.08
Clinical judgement high risk for delirium, 0–1 2.39 0.72 to 7.87 0.15 1.48 0.32 to 6.88 0.62
Postoperative
Complications 1.77 0.28 to 11.27 0.55 4.81 1.03 to 22.38 0.05*
Incidence of delirium 1.06 0.28 to 4.00 0.93
*p<0.05.
EuroSCORE, European System for Cardiac Operative Risk Evaluation.
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DISCUSSION
To our best knowledge, this study is the ﬁrst to reveal a
relation between objective frailty assessment with delir-
ium in a speciﬁc group of patients after TAVI.
The ﬁnding that this relation was independent from
cardiological assessment (table 3) suggests that frailty
assessment may have additional value, by identifying
patients at increased risk of delirium after TAVI.
Previous investigators found frailty related to delirium
after cardiac surgery.20 However, in contrast to our study,
Eide et al15 found no relation between frailty and delirium
after TAVI. The differences found in our study compared
with the study from Eide et al15 may be related to differ-
ences in study design: (1) our study population is speciﬁc
to TAVI, while their population includes patients after
TAVI or surgical aortic valve replacement, (2) the number
of patients after TAVI in our study group is higher, (3) our
study group comprises consecutive patients, whereas their
study group is restricted to octogenarians and (4) our
study uses frailty assessment, with various separate
variables, instead of one combined variable for frailty, in
addition to Mini Mental State Examination. Our ﬁnding
that cognitive function was related to delirium is in
accordance with previous ﬁndings.15 23
The ﬁnding in our study that pulmonary hypertension
was protectively associated with delirium was unex-
pected. Abawi et al16 found no signiﬁcant relation
between pulmonary hypertension and delirium after
TAVI, whereas Eide et al15 provide no results for the vari-
able pulmonary hypertension. The protective association
between pulmonary hypertension and delirium is not
easily explained and may be the result of the selection
of frail patients to undergo TAVI, even in the absence of
high cardiac risk. This argumentation is supported by
the predictive association between frailty variables and
delirium, while cardiac risk, as expressed in the
EuroSCORE, is not associated with delirium. Further
research on this subject is warranted.
In contrast to previous studies, we found no relation
between postprocedural complications and delirium.16
Table 3 Variables associated with delirium and mortality after transcatheter aortic valve implantation (TAVI), multivariate
logistic regression analysis and Cox proportional hazards regression analysis
Delirium
p Value
OR 95% CI R2=0.359
Age 1.04 0.93 to 1.17 0.47
Pulmonary hypertension 0.31 0.10 to 1.04 0.06
Mini Mental State Examination 0.73 0.53 to 0.99 0.04*
Instrumental Activities of Daily Living 1.30 0.81 to 2.10 0.28
Timed up and Go 1.15 0.99 to 1.34 0.08
Mortality HR 95% CI
p Value
R2=0.271
Age 0.94 0.84 to 1.06 0.32
Frailty Index 1.82 1.04 to 3.18 0.04*
EuroSCORE II 1.13 1.05 to 1.22 0.002*
Complications 4.31 0.89 to 20.95 0.07
*Significance level p<0.05.
EuroSCORE, European System for Cardiac Operative Risk Evaluation.
Table 4 Mean values (SD) for the variables significantly associated with delirium and mortality for the groups with or without
the occurrence of delirium and mortality, respectively
Delirium No, n=64 Yes, n=25 p Value
Pulmonary hypertension >30 mm Hg, n (%) 42/53 (79) 13/23 (57) 0.04*
Mini-Mental State Examination, mean (SD), (range 0–30) 27.5 (2.3) 26.0 (2.6) 0.01*
Instrumental Activities of Daily Living, mean (SD), (range 0–8) 6.7 (1.7) 5.6 (2.5) 0.07
Gait speed, mean (SD), m/s 0.9 (0.3) 0.7 (0.3) <0.01*
Timed Up and Go, mean (SD), seconds 11.5 (4.7) 16.6 (8.5) 0.03*
Mortality No, n=78 Yes, n=11 p Value
Frailty Index, mean (SD) 2.2 (1.4) 3.4 (1.6) 0.02*
EuroSCORE I, mean (SD) 14.6 (8.8) 24.7 (12.7) 0.00*
EuroSCORE II, mean (SD) 4.8 (3.8) 10.3 (9.1) 0.00*
Complications, n (%) 3 (3.8) 2 (18.2) 0.27
*Significance level p<0.05.
EuroSCORE, European System for Cardiac Operative Risk Evaluation.
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The association of variables from frailty assessment
with delirium is found in our study, even after selection
of patients, which procedure tends to exclude patients
with lower and higher risk factors. In our selection
process patients with lower and higher risk were assigned
to surgical aortic valve replacement and medical treat-
ment, respectively. This selection process may explain
the absence of a substantial association of age with delir-
ium in our study, in contrast to observations in other
studies.24 In addition, we found no substantial associ-
ation of weight and body mass index with delirium, in
contrast to Smulter et al.25 Furthermore, they found no
relation between impaired Mini Mental State
Examination and delirium after cardiac surgery.25
However, they used Mini Mental State Examination both
as a diagnostic tool and predictive factor for delirium,
which may have been a confounding factor.
The incidence of delirium after TAVI in our study
(28.1%) is comparable to the incidence reported by
previous studies examining delirium after TAVI
(12–53%)14 15 or cardiac surgery (26–66%).24–27 The
observed incidence of delirium in our study may have
been inﬂuenced by several factors: (a) transfer of the
patient (from intensive care unit to cardiac care unit),
(b) general anaesthesia, (c) strict patient follow-up by
the geriatric consultation team and (d) preventive guide-
lines. Although delirium after cardiac surgery is
common, previous investigators show that the incidence
of delirium will be easily under-recognised clinically,
without an appropriate strategy for diagnosis.23 Thus, a
low incidence of delirium after TAVI reported by others
(11.5%)28 may have resulted from under-recognition.
Considering the high incidence of delirium and the
impact on morbidity and costs, the need for prevention
of delirium after TAVI is ampliﬁed.
In our study variables from frailty assessment and car-
diological assessment were independently associated
with mortality (table 3), which suggests that frailty assess-
ment may have additional value to the prediction of
mortality after TAVI, in accordance with previous
studies.8–10
The absence of a relation between the incidence of
delirium and mortality after TAVI in our study, in con-
trast to previous studies,16 17 is not conclusive, due to
the limited absolute number of patients with delirium
and mortality. However, in our study, accurate diagnosis
followed by treatment of delirium may have resulted in
reduced mortality after delirium.
Limitations
The absolute number of patients studied with the events
delirium or mortality after TAVI is limited. However, ana-
lysis of this limited number of patients still provides valu-
able conclusions with regard to variables associated with
delirium and mortality.
This study on association of frailty assessment with
delirium and mortality is analysed in a selected popula-
tion, whereas the selection procedure for treatment
assignment is based on multidisciplinary decision-
making, which may have been inﬂuenced by the same
frailty assessment. However, since selection may have led
to exclusion of patients with the more extreme values,
the associations found may be underestimated, not
overestimated.
Owing to multiple testing some caution should be
used when interpreting the ﬁndings of the multiple uni-
variate tests as there may be a risk of an inﬂated type I
error rate, considering the large number of tests in the
analysis. However, subject knowledge corroborates and
further research may corroborate our ﬁndings.
The incidence of delirium in our study population
may have been inﬂuenced by general anaesthesia, rou-
tinely performed in TAVI procedures in our centre with
primarily subclavian access, whereas local anaesthesia is
performed in other centres. In addition, the access site
may have inﬂuenced the incidence of delirium, as previ-
ous investigators showed difference in incidence of delir-
ium related to the access site of the TAVI procedure
(transfemoral vs transapical).14 Moreover, the preventive
use of haloperidol in 5/89 patients may have inﬂuenced
the incidence of delirium. However, previous investiga-
tors found no effect of haloperidol in prevention of
postoperative delirium.29
CONCLUSIONS
Delirium frequently occurs after TAVI. Variables from
frailty assessment are associated with delirium, inde-
pendent from cardiological assessment: Mini Mental
State Examination, Instrumental Activities of Daily
Living, gait speed and TUG. The summary score Frailty
Index is associated with mortality, independent from car-
diological assessment. Thus, frailty assessment may have
additional value in the prediction of delirium and mor-
tality after TAVI. Therefore, the cardiologist might con-
sider involvement of a geriatrician for risk assessment in
the selection of patients for TAVI. Further study is
required in a broader range of patients.
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